Anti-LSHR/ LHCGR/ HHG monoclonal antibody

Anti-LSHR/ LHCGR/ HHG antibody for FACS & in-vivo assay

Target products collectionGo to LHCGR/LHCGR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T79473-Ab-1/ GM-Tg-hg-T79473-Ab-2Anti-Human LHCGR monoclonal antibodyHuman
GM-Tg-rg-T79473-Ab-1/ GM-Tg-rg-T79473-Ab-2Anti-Rat LHCGR monoclonal antibodyRat
GM-Tg-mg-T79473-Ab-1/ GM-Tg-mg-T79473-Ab-2Anti-Mouse LHCGR monoclonal antibodyMouse
GM-Tg-cynog-T79473-Ab-1/ GM-Tg-cynog-T79473-Ab-2Anti-Cynomolgus/ Rhesus macaque LHCGR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T79473-Ab-1/ GM-Tg-felg-T79473-Ab-2Anti-Feline LHCGR monoclonal antibodyFeline
GM-Tg-cang-T79473-Ab-1/ GM-Tg-cang-T79473-Ab-2Anti-Canine LHCGR monoclonal antibodyCanine
GM-Tg-bovg-T79473-Ab-1/ GM-Tg-bovg-T79473-Ab-2Anti-Bovine LHCGR monoclonal antibodyBovine
GM-Tg-equg-T79473-Ab-1/ GM-Tg-equg-T79473-Ab-2Anti-Equine LHCGR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T79473-Ab-1/ GM-Tg-hg-T79473-Ab-2; GM-Tg-rg-T79473-Ab-1/ GM-Tg-rg-T79473-Ab-2;
GM-Tg-mg-T79473-Ab-1/ GM-Tg-mg-T79473-Ab-2; GM-Tg-cynog-T79473-Ab-1/ GM-Tg-cynog-T79473-Ab-2;
GM-Tg-felg-T79473-Ab-1/ GM-Tg-felg-T79473-Ab-2; GM-Tg-cang-T79473-Ab-1/ GM-Tg-cang-T79473-Ab-2;
GM-Tg-bovg-T79473-Ab-1/ GM-Tg-bovg-T79473-Ab-2; GM-Tg-equg-T79473-Ab-1/ GM-Tg-equg-T79473-Ab-2
Products NameAnti-LHCGR monoclonal antibody
Formatmab
Target NameLHCGR
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LHCGR benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-INN-778Pre-Made Choriogonadotropin Beta Biosimilar, Recombinant Protein targeting LHCGR: Recombinant therapeutic protein targeting HHG/LCGR/LGR2/LH/CG-R/LH/CGR/LHR/LHRHR/LSH-R/ULG5
    Target AntigenProducts DevelopingMulti-species LSHR/ LHCGR/ HHG VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-T79473
    Target NameLHCGR
    Gene ID3973,16867,25477,715999,481365,101088154,281900,100034043
    Gene Symbol and SynonymsGpcr19-rs1,HHG,LCGR,LGR2,LH-R,LH/CG-R,LH/CGR,LHCGR,LHR,LHRHR,LSH-R,LSHR,ULG5
    Uniprot AccessionP22888,P16235,Q28005
    Uniprot Entry NameLSHR_HUMAN,LSHR_RAT,LSHR_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, INN Index
    DiseaseCancer
    Gene EnsemblENSG00000138039
    Target ClassificationGPCR, Tumor-associated antigen (TAA)

    The target: LHCGR, gene name: LHCGR, also named as HHG, LCGR, LGR2, LH/CG-R, LH/CGR, LHR, LHRHR, LSH-R, ULG5. This gene encodes the receptor for both luteinizing hormone and choriogonadotropin. This receptor belongs to the G-protein coupled receptor 1 family, and its activity is mediated by G proteins which activate adenylate cyclase. Mutations in this gene result in disorders of male secondary sexual character development, including familial male precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.